Folgen
Dominik Selzer
Dominik Selzer
Clinical Pharmacy - Saarland University; Scientific Consilience GmbH
Bestätigte E-Mail-Adresse bei uni-saarland.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Proteomic and lipidomic analysis of nanoparticle corona upon contact with lung surfactant reveals differences in protein, but not lipid composition
SS Raesch, S Tenzer, W Storck, A Rurainski, D Selzer, CA Ruge, ...
ACS nano 9 (12), 11872-11885, 2015
1522015
Finite and infinite dosing: Difficulties in measurements, evaluations and predictions
D Selzer, MMA Abdel-Mottaleb, T Hahn, UF Schaefer, D Neumann
Advanced drug delivery reviews 65 (2), 278-294, 2013
1282013
Towards drug quantification in human skin with confocal Raman microscopy
L Franzen, D Selzer, JW Fluhr, UF Schaefer, M Windbergs
European journal of pharmaceutics and biopharmaceutics 84 (2), 437-444, 2013
732013
Nanocarriers for optimizing the balance between interfollicular permeation and follicular uptake of topically applied clobetasol to minimize adverse effects
C Mathes, A Melero, P Conrad, T Vogt, L Rigo, D Selzer, WA Prado, ...
Journal of Controlled Release 223, 207-214, 2016
632016
An extended database of keratin binding
S Hansen, D Selzer, UF Schaefer, GB Kasting
Journal of pharmaceutical sciences 100 (5), 1712-1726, 2011
482011
Data digitizing: accurate and precise data extraction for quantitative systems pharmacology and physiologically‐based pharmacokinetic modeling
JG Wojtyniak, H Britz, D Selzer, M Schwab, T Lehr
CPT: pharmacometrics & systems pharmacology 9 (6), 322-331, 2020
372020
Finite dose skin mass balance including the lateral part: comparison between experiment, pharmacokinetic modeling and diffusion models
D Selzer, T Hahn, A Naegel, M Heisig, KH Kostka, CM Lehr, D Neumann, ...
Journal of controlled release 165 (2), 119-128, 2013
272013
A comprehensive whole-body physiologically based pharmacokinetic drug–drug–gene interaction model of metformin and cimetidine in healthy adults and renally impaired individuals
N Hanke, D Türk, D Selzer, N Ishiguro, T Ebner, S Wiebe, F Müller, ...
Clinical pharmacokinetics 59 (11), 1419-1431, 2020
232020
Physiologically-based pharmacokinetic (PBPK) modeling of buprenorphine in adults, children and preterm neonates
L Kovar, C Schräpel, D Selzer, Y Kohl, R Bals, M Schwab, T Lehr
Pharmaceutics 12 (6), 578, 2020
202020
Physiologically based precision dosing approach for drug‐drug‐gene interactions: A simvastatin network analysis
JG Wojtyniak, D Selzer, M Schwab, T Lehr
Clinical Pharmacology & Therapeutics 109 (1), 201-211, 2021
192021
Mathematical models for dermal drug absorption
D Selzer, D Neumann, UF Schaefer
Expert Opinion on Drug Metabolism & Toxicology 11 (10), 1567-1583, 2015
152015
Influence of the application area on finite dose permeation in relation to drug type applied
T Hahn, D Selzer, D Neumann, KH Kostka, CM Lehr, UF Schaefer
Experimental dermatology 21 (3), 233-235, 2012
152012
Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach
LM Fuhr, FZ Marok, N Hanke, D Selzer, T Lehr
Pharmaceutics 13 (2), 270, 2021
102021
Physiologically based pharmacokinetic modeling of metoprolol enantiomers and α-hydroxymetoprolol to describe CYP2D6 drug-gene interactions
S Rüdesheim, JG Wojtyniak, D Selzer, N Hanke, F Mahfoud, M Schwab, ...
Pharmaceutics 12 (12), 1200, 2020
102020
A strategy for in-silico prediction of skin absorption in man
D Selzer, D Neumann, H Neumann, KH Kostka, CM Lehr, UF Schaefer
European Journal of Pharmaceutics and Biopharmaceutics 95, 68-76, 2015
92015
Physiologically based pharmacokinetic modeling of bupropion and its metabolites in a CYP2B6 drug-drug-gene interaction network
FZ Marok, LM Fuhr, N Hanke, D Selzer, T Lehr
Pharmaceutics 13 (3), 331, 2021
82021
Basic mathematics in skin absorption
D Selzer, UF Schaefer, CM Lehr, S Hansen
Percutaneous Penetration Enhancers Drug Penetration Into/Through the Skin, 3-25, 2017
82017
A mechanistic, Enantioselective, physiologically based pharmacokinetic model of verapamil and Norverapamil, built and evaluated for drug–drug interaction studies
N Hanke, D Türk, D Selzer, S Wiebe, É Fernandez, P Stopfer, V Nock, ...
Pharmaceutics 12 (6), 556, 2020
72020
Comprehensive parent–metabolite PBPK/PD modeling insights into nicotine replacement therapy strategies
L Kovar, D Selzer, H Britz, N Benowitz, G St Helen, Y Kohl, R Bals, T Lehr
Clinical pharmacokinetics 59 (9), 1119-1134, 2020
62020
Novel models for the prediction of drug–gene interactions
D Türk, LM Fuhr, FZ Marok, S Rüdesheim, A Kühn, D Selzer, M Schwab, ...
Expert Opinion on Drug Metabolism & Toxicology 17 (11), 1293-1310, 2021
42021
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20